Table 2 Summary of the clinical outcomes in the ICP patients
Outcome | AHCa (n = 169) | HCb (n = 49) | FHTc (n = 27) | Test statistic | All subjects (n = 246) | Base vs. EoT (paired t-test)d |
|---|---|---|---|---|---|---|
Completion rate, % | 74.1% | 65.3% | 59.3% | χ2 = 3.35, df = 2, p = 0.19 | 70.7% | – |
Treatment duration, mean (SD) | 134.09 (106.51) | 99.31 (43.26) | 103.11 (30.23) | F = 3.527, df = 2, p = 0.031 | 123.76 (92.36) | |
Number of physician visits, mean (SD) | 7.65 (4.19) | 5.88 (2.64) | 6.89 (3.30) | F = 4.183, df = 2, p = 0.016 | 7.26 (3.89) | |
Number of therapy sessions, mean (SD) | 10.95 (6.03) | 12.45 (4.47) | 11.41 (6.54) | F = 1.209 df = 2, p = 0.300 | 11.30 (5.82) | |
Changes in clinical parameters | ||||||
Reduction in SD/w, mean (SD) | 25.35 (37.06) | 13.39 (26.01) | 16.08 (24.03) | F = 2.407, df = 2, p = 0.093 | 22.19 (34.46) | t = 9.53, p < 0.001 |
Reduction in SD/d, mean (SD) | 3.57 (6.09) | 2.08 (4.05) | 3.03 (2.93) | F = 1.251, df = 2, p = 0.288 | 3.23 (5.56) | t = 8.65, p < 0.001 |
Reduction in HDD/w, mean (SD) | 2.63 (3.34) | 2.06 (2.98) | 1.11 (2.64) | F = 2.107, df = 2, p = 0.124 | 2.39 (3.24) | t = 10.95, p < 0.001 |
Reduction in DD/w, mean (SD) | 2.12 (3.16) | 1.23 (2.85) | 0.44 (1.86) | F = 3.511, df = 2, p = 0.032 | 1.81 (3.05) | t = 8.78, p < 0.001 |
Reduction in PACS, mean (SD) | 4.57 (8.29) | 4.27 (7.38) | 3.78 (6.35) | F = 0.128, df = 2, p = 0.880 | 4.42 (7.88) | t = 8.63, p < 0.001 |
Reduction in QIDS, mean (SD) | 4.17 (6.22) | 4.74 (4.94) | 3.77 (3.84) | F = 0.262, df = 2, p = 0.77 | 4.25 (5.76) | t = 11.26, p < 0.001 |